NDC 0023-5874
Byvalson
Nebivolol Hydrochloride And Valsartan
Byvalson is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Nebivolol Hydrochloride; Valsartan.
| Product ID | 0023-5874_6964c0d8-8223-4992-b42c-43d3de03080e |
| NDC | 0023-5874 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Byvalson |
| Generic Name | Nebivolol Hydrochloride And Valsartan |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-06-03 |
| Marketing Category | NDA / NDA |
| Application Number | NDA206302 |
| Labeler Name | Allergan, Inc. |
| Substance Name | NEBIVOLOL HYDROCHLORIDE; VALSARTAN |
| Active Ingredient Strength | 5 mg/1; mg/1 |
| Pharm Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
Packaging
NDC 0023-5874-90
90 TABLET, FILM COATED in 1 BOTTLE (0023-5874-90)
| Marketing Start Date | 2016-06-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0023-5874-32 [00023587432]
Byvalson TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA206302 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-06-03 |
| Marketing End Date | 2019-05-31 |
NDC 0023-5874-07 [00023587407]
Byvalson TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA206302 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-06-03 |
| Marketing End Date | 2019-05-31 |
NDC 0023-5874-90 [00023587490]
Byvalson TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA206302 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-06-03 |
| Marketing End Date | 2019-05-31 |
NDC 0023-5874-84 [00023587484]
Byvalson TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA206302 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-06-03 |
| Marketing End Date | 2019-05-31 |
NDC 0023-5874-31 [00023587431]
Byvalson TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA206302 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-06-03 |
| Marketing End Date | 2019-05-31 |
NDC 0023-5874-30 [00023587430]
Byvalson TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA206302 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-06-03 |
| Marketing End Date | 2019-05-31 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| NEBIVOLOL HYDROCHLORIDE | 5 mg/1 |
OpenFDA Data
| SPL SET ID: | b4ad6a5b-e69d-4b39-9fe3-58569a964978 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Pharmacological Class
- Adrenergic beta-Antagonists [MoA]
- beta-Adrenergic Blocker [EPC]
- Angiotensin 2 Receptor Antagonists [MoA]
- Angiotensin 2 Receptor Blocker [EPC]
Trademark Results [Byvalson]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BYVALSON 86101968 5073605 Live/Registered |
ALLERGAN SALES, LLC 2013-10-25 |
© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.